A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)

  • Etude concernée: IFCT-0803
  • Auteurs / Authors: Tredaniel J, Mornex F, Barillot I, Diaz O, Hennequin C, Le Pechoux C, Lavole A, Giraud P, Souquet PJ, Teixeira L, Vaylet F, Zalcman G, Baudrin L, Morin F, Milleron B
  • Journal / Conference: Revue des Maladies Respiratoires
  • Année / Year: 2011
  • PMID: 21277474
  • Lien vers la publication: https://www.ncbi.nlm.nih.gov/pubmed/21277474